Growth Metrics

Omeros (OMER) Interest Coverage Ratio (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.31%
Dec 31, 2025 -268.64%
Sep 30, 2025 100.09%
Jun 30, 2025 -22,438.35%
Mar 31, 2025 8.85%
Dec 31, 2024 -20.15%
Sep 30, 2024 -36.12%
Jun 30, 2024 -35.37%
Mar 31, 2024 15.77%
Dec 31, 2023 7.45%
Sep 30, 2023 -17.97%
Jun 30, 2023 -14.54%
Mar 31, 2023 11.36%
Dec 31, 2022 50.66%
Sep 30, 2022 -35.46%
Jun 30, 2022 -7.13%
Mar 31, 2022 18.12%
Dec 31, 2021 -6.82%
Sep 30, 2021 12.69%
Jun 30, 2021 -0.44%
Mar 31, 2021 -118.47%
Dec 31, 2020 -14.57%
Sep 30, 2020 20.20%
Jun 30, 2020 -15.44%
Mar 31, 2020 1.67%
Dec 31, 2019 -110.00%
Sep 30, 2019 -15.03%
Jun 30, 2019 50.85%
Mar 31, 2019 4.26%
Dec 31, 2018 53.40%
Sep 30, 2018 7.53%
Jun 30, 2018 15.02%
Mar 31, 2018 -98.79%
Dec 31, 2017 -168.24%
Sep 30, 2017 58.08%
Jun 30, 2017 8.24%
Mar 31, 2017 1.18%
Dec 31, 2016 14.24%
Sep 30, 2016 4.20%
Jun 30, 2016 58.40%
Mar 31, 2016 36.64%
Dec 31, 2015 -0.75%
Sep 30, 2015 -30.04%
Jun 30, 2015 9.05%
Mar 31, 2015 14.18%
Dec 31, 2014 -20.29%
Sep 30, 2014 1.02%
Jun 30, 2014 21.44%
Mar 31, 2014 -0.39%
Dec 31, 2013 -2.45%
Sep 30, 2013 -1.56%
Jun 30, 2013 -30.89%
Mar 31, 2013 16.38%
Dec 31, 2012 35.32%
Sep 30, 2012 -73.44%
Jun 30, 2012 -11.37%
Mar 31, 2012 11.06%
Dec 31, 2011 -57.37%
Sep 30, 2011 -24.31%
Jun 30, 2011 57.34%
Mar 31, 2011 19.74%
Dec 31, 2010 -32.55%
Sep 30, 2010 -10.85%